Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
NM
NEA Management Company, LLC
|
13.2M | 9.28% | Unchanged | ≤2021 | 15.5% | |
|
Shares held by quarter
Peak holding13.2M (Q2'25)
Change over 8 quarters+1.9M
Share of the company9.280%
|
||||||
|
F
FMR LLC
|
12.6M | 8.82% | +4.5M (+56.3%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding12.6M (Q2'26)
Change over 8 quarters+12.6M
Share of the company8.820%
|
||||||
28 more super investors behind a free account
See every manager holding Trevi Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$75.5M | 4.0M | 2.84% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$51.3M | 2.8M | 1.93% | 0.06% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Trevi Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
N1
Nea 18 Vge GP, LLC
5%+ holder
13D · 10.5%
|
15.1M | 10.58% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
NP
NEA Partners 18 VGE, L.P.
5%+ holder
13D · 10.5%
|
15.1M | 10.58% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
17 more holders behind a free account
See every insider and 5%+ holder of Trevi Therapeutics, Inc..
Sign up freeLoading...